Jane Street Group, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.76 - $5.52 $2,757 - $5,514
999 Added 3.43%
30,090 $113,000
Q4 2023

Feb 14, 2024
BUY
$3.56 - $6.04 $103,563 - $175,709
29,091 New
29,091 $149,000
Q3 2022

Nov 14, 2022
BUY
$0.14 - $2.66 $2,405 - $45,698
17,180 New
17,180 $27,000

Others Institutions Holding RVPH

# of Institutions
40
Shares Held
9.97M
Call Options Held
133K
Put Options Held
43.9K
View Full List

About REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH Quotes by TradingView
  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $26M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email